318 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
with any person or entity other than the corporation with respect to any direct or indirect compensation or reimbursement for service as a Director that has
S-8
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement
8-K
jtgk jg3khm6q
5 Jan 24
Other Events
5:50pm
8-K
5wus6y shrca0
1 Dec 23
Entry into a Material Definitive Agreement
8:25am
8-K
tqmxdgye84u1ozt
18 Oct 23
Other Events
9:03am
8-K
EX-10.1
fxhnyt93s6 tev
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
zq7enddla1l58
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
S-8
0ckc9
10 Aug 22
Registration of securities for employees
4:05pm
S-8
lkqw4kna1g797si7 46
13 Jun 22
Registration of securities for employees
8:44am
425
ur1rdm y7u
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
af2w0i vde
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
ra1jvlh4c23y epsaq
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
4kagthpl
24 Mar 22
Entry into a Material Definitive Agreement
9:08am